<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p95" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_95{left:411px;top:233px;letter-spacing:-0.1px;}
#t2_95{left:411px;top:78px;letter-spacing:-0.3px;}
#t3_95{left:415px;top:630px;letter-spacing:-0.9px;}
#t4_95{left:65px;top:40px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t5_95{left:65px;top:58px;letter-spacing:-1px;}
#t6_95{left:73px;top:58px;letter-spacing:-0.9px;word-spacing:-1.1px;}
#t7_95{left:73px;top:73px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#t8_95{left:65px;top:90px;letter-spacing:-1px;}
#t9_95{left:73px;top:90px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#ta_95{left:130px;top:90px;letter-spacing:-0.9px;}
#tb_95{left:65px;top:108px;letter-spacing:-0.9px;word-spacing:2.9px;}
#tc_95{left:65px;top:123px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#td_95{left:105px;top:123px;letter-spacing:-1px;}
#te_95{left:144px;top:123px;letter-spacing:-1px;word-spacing:-0.1px;}
#tf_95{left:65px;top:141px;letter-spacing:-1px;word-spacing:0.6px;}
#tg_95{left:222px;top:141px;letter-spacing:-1px;}
#th_95{left:268px;top:141px;letter-spacing:-0.9px;word-spacing:0.5px;}
#ti_95{left:65px;top:156px;letter-spacing:-1px;word-spacing:3.5px;}
#tj_95{left:65px;top:171px;letter-spacing:-1px;}
#tk_95{left:70px;top:198px;}
#tl_95{left:70px;top:218px;}
#tm_95{left:70px;top:238px;}
#tn_95{left:70px;top:257px;}
#to_95{left:70px;top:277px;}
#tp_95{left:70px;top:296px;}
#tq_95{left:109px;top:296px;}
#tr_95{left:70px;top:316px;}
#ts_95{left:70px;top:335px;}
#tt_95{left:70px;top:354px;}
#tu_95{left:70px;top:373px;}
#tv_95{left:81px;top:385px;}
#tw_95{left:81px;top:397px;}
#tx_95{left:86px;top:397px;}
#ty_95{left:86px;top:409px;}
#tz_95{left:81px;top:422px;}
#t10_95{left:86px;top:422px;}
#t11_95{left:86px;top:434px;}
#t12_95{left:128px;top:434px;}
#t13_95{left:70px;top:452px;}
#t14_95{left:70px;top:471px;}

.s1_95{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_95{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_95{
	FONT-SIZE: 37.6px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_95{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.s5_95{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s6_95{
	FONT-SIZE: 36.7px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(255,255,255);
}

.s7_95{
	FONT-SIZE: 36.7px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.t.m0_95{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts95" type="text/css" >

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg95Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg95" style="-webkit-user-select: none;"><object width="433" height="649" data="95/95.svg" type="image/svg+xml" id="pdf95" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_95" class="t m0_95 s1_95">O Guia do Jovem Internista </div>
<div id="t2_95" class="t m0_95 s2_95">2016</div>
<div id="t3_95" class="t s3_95">93</div>
<div id="t4_95" class="t s4_95">• Trombólise</div>
<div id="t5_95" class="t s4_95">• </div>
<div id="t6_95" class="t s5_95">Até 4.5h após o início dos sintomas ou a partir do momento em que o </div>
<div id="t7_95" class="t s5_95">doente foi visto pela última vez sem sintomas. </div>
<div id="t8_95" class="t s4_95">• </div>
<div id="t9_95" class="t s5_95">Em doentes </div>
<div id="ta_95" class="t s4_95">hipocoagulados: </div>
<div id="tb_95" class="t s5_95">A terapêutica trombolítica não deve ser efectuada nas 1as 48h após a </div>
<div id="tc_95" class="t s5_95">toma de </div>
<div id="td_95" class="t s4_95">NOAC’s</div>
<div id="te_95" class="t s5_95">(8-17h de semivida).</div>
<div id="tf_95" class="t s5_95">Nos doentes sob terapêutica com </div>
<div id="tg_95" class="t s4_95">varfarina</div>
<div id="th_95" class="t s5_95">a trombólise só deverá ser </div>
<div id="ti_95" class="t s5_95">realizada mediante os resultados do INR (INR &lt; 1,7- EUA; INR&lt; 1,5 - </div>
<div id="tj_95" class="t s5_95">Europa).</div>
<div id="tk_95" class="t s6_95">Critérios de Exclusão</div>
<div id="tl_95" class="t s7_95">Traumatismo CE significativo ou AVC nos últimos 3 meses</div>
<div id="tm_95" class="t s7_95">Sintomas sugestivos de hemorragia subaracnóidea.</div>
<div id="tn_95" class="t s7_95">Punção arterial em local não compressível nos últimos 7 dias.</div>
<div id="to_95" class="t s7_95">História de Hemorragia Intracraniana.</div>
<div id="tp_95" class="t s7_95">Neoplasia </div>
<div id="tq_95" class="t s7_95">intracraniana, MAV ou aneurisma.</div>
<div id="tr_95" class="t s7_95">Cirurgia intracraniana ou intraespinal recente.</div>
<div id="ts_95" class="t s7_95">Hipertensão Arterial (TAS&gt; 185 mmHg, TAD &gt; 110 mmHg).</div>
<div id="tt_95" class="t s7_95">Hemorragia interna ativa.</div>
<div id="tu_95" class="t s7_95">Diátese hemorrágica:</div>
<div id="tv_95" class="t s7_95">- Plaquetas &lt; 100 000 / mm3</div>
<div id="tw_95" class="t s7_95">- </div>
<div id="tx_95" class="t s7_95">Administração de heparina nas últimas 48h, com aPTT acima do limite superior </div>
<div id="ty_95" class="t s7_95">do normal</div>
<div id="tz_95" class="t s7_95">- </div>
<div id="t10_95" class="t s7_95">Uso de inibidores diretos da trombina ou inibidores do factor Xa, com alteração </div>
<div id="t11_95" class="t s7_95">dos testes </div>
<div id="t12_95" class="t s7_95">sensíveis</div>
<div id="t13_95" class="t s7_95">Glucose Plasmática &lt; 50 mg/dl.</div>
<div id="t14_95" class="t s7_95">TC CE demostrando enfarte multilobar (&gt; 1/3 de um hemisfério)</div>

<!-- End text definitions -->


</div>
</body>
</html>
